Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer

Predicting EGFR Mutation Status in Lung Adenocarcinoma on CT Image Using Deep Learning

(2019) Shuo Wang et al.   EUROPEAN RESPIRATORY JOURNAL

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?

(2019) Subba R. Digumarthy et al.   MEDICINE

Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis

(2018) Yong-il Kim et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Are liquid biopsies a surrogate for tissue EGFR testing?

(2018) J W Goldman et al.   ANNALS OF ONCOLOGY

Overview of current systemic management of EGFR-mutant NSCLC

(2018) W -H Hsu et al.   ANNALS OF ONCOLOGY

LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity

(2018) Christophe Nioche et al.   CANCER RESEARCH

Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions

(2018) Margarita Kirienko et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules

(2018) Yunlang She et al.   EUROPEAN RADIOLOGY

Challenges and Promises of PET Radiomics

(2018) Gary J.R. Cook et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions

(2018) Weihua Li et al.   Molecular Oncology

Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer

(2018) Liwen Zhang et al.   Translational Oncology

Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancer

(2018) Tae-Ok Kim et al.   Thoracic Cancer

Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma

(2017) Kazuya Takamochi et al.   PLoS One

Radiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung Adenocarcinoma

(2017) Zhang Shi et al.   Scientific Reports

Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas

(2016) Ying Liu et al.   Clinical Lung Cancer

Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non–Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort

(2016) Marie-Charlotte Desseroit et al.   JOURNAL OF NUCLEAR MEDICINE

Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non–Small Cell Lung Cancer

(2016) Stephen S.F. Yip et al.   JOURNAL OF NUCLEAR MEDICINE

EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients

(2016) Na An et al.   MEDICINE

CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma

(2016) Ying Liu et al.   RADIOLOGY

CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung

(2015) Efe Ozkan et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

FDG Uptake in Non–Small Cell Lung Cancer Is Not an Independent Predictor of EGFR or KRAS Mutation Status

(2015) Seok Mo Lee et al.   CLINICAL NUCLEAR MEDICINE

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

(2015) Stefania Rizzo et al.   EUROPEAN RADIOLOGY

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

(2014) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

(2014) Yuankai Shi et al.   Journal of Thoracic Oncology

Behind the Numbers: Decoding Molecular Phenotypes with Radiogenomics—Guiding Principles and Technical Considerations

(2014) Michael D. Kuo et al.   RADIOLOGY

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

(2014) Hugo J. W. L. Aerts et al.   Nature Communications

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

(2012) S. Dogan et al.   CLINICAL CANCER RESEARCH

Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase Activity

(2008) Zhang Weihua et al.   CANCER CELL